Circulating miRNA signatures to predict recurrence in patients with pathological complete response of triple-negative breast cancer

被引：0
|
作者：
de Freitas, A. J. A. [1 ]
Nunes, C. R. [2 ]
Causin, R. L. [2 ]
Calfa, S. [1 ]
de Oliveira, M. A. [3 ]
de Padua Souza, C. [4 ]
Marques, M. M. C. [1 ]
机构：
[1] Barretos Canc Hosp, Mol Oncol Res Ctr, Barretos, Brazil
[2] Barretos Canc Hosp, Ctr Oncol Mol, Barretos, Brazil
[3] Barretos Canc Hosp, Nucleus Epidemiol & Biostat, Sao Paulo, Brazil
[4] Hosp Amor, Oncol Dept, Fundacao Pio XII, Hosp Canc Barretos, Barretos, SP, Brazil
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1551
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
49P
引用
收藏
页码：S202 / S202
页数：1
相关论文
共 50 条
  • [1] Circulating Micro-RNAs Predict the Risk of Recurrence in Triple-Negative Breast Cancer
    Kujala, Jouni
    Tengstrom, Maria
    Heikkinen, Sami
    Taipale, Mari
    Kosma, Veli-Matti
    Hartikainen, Jaana M.
    Mannermaa, Arto
    CELLS, 2024, 13 (22)
  • [2] Association of pathological complete response rates and TILs in triple-negative breast cancer patients.
    Kassem, Mahmoud
    Goldstein, Daniel
    Schnell, Patrick
    Grimm, Michael
    Quiroga, Dionisia Marie
    Miah, Abdul
    Vargo, Craig
    Shinde, Namrata Vilas
    Michael, Berger
    Pariser, Ashley
    Gatti-Mays, Margaret Elena
    VanDeusen, Jeffrey Bryan
    Williams, Nicole Olivia
    Stover, Daniel G.
    Sardesai, Sagar D.
    Wesolowski, Robert
    Lustberg, Maryam B.
    Ramaswamy, Bhuvaneswari
    Tozbikian, Gary
    Cherian, Mathew Amprayil
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
    Paul Gass
    Michael P. Lux
    Claudia Rauh
    Alexander Hein
    Mayada R. Bani
    Cornelia Fiessler
    Arndt Hartmann
    Lothar Häberle
    Jutta Pretscher
    Ramona Erber
    David L. Wachter
    Rüdiger Schulz-Wendtland
    Matthias W. Beckmann
    Peter A. Fasching
    Marius Wunderle
    BMC Cancer, 18
  • [4] Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
    Gass, Paul
    Lux, Michael P.
    Rauh, Claudia
    Hein, Alexander
    Bani, Mayada R.
    Fiessler, Cornelia
    Hartmann, Arndt
    Haeberle, Lothar
    Pretscher, Jutta
    Erber, Ramona
    Wachter, David L.
    Schulz-Wendtland, Ruediger
    Beckmann, Matthias W.
    Fasching, Peter A.
    Wunderle, Marius
    BMC CANCER, 2018, 18
  • [5] Bevacizumab in Neoadjuvant Chemotherapy Increases the Pathological Complete Response Rate in Patients With Triple-Negative Breast Cancer
    Barton, Mary Kay
    CA-A CANCER JOURNAL FOR CLINICIANS, 2014, 64 (03) : 155 - 156
  • [6] Collagen Density Is Associated With Pathological Complete Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients
    Li, Fengling
    Wei, Yani
    Li, Li
    Chen, Fei
    Bao, Chunjuan
    Bu, Hong
    Zhang, Zhang
    JOURNAL OF SURGICAL ONCOLOGY, 2024,
  • [7] Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
    Nakashoji, Ayako
    Matsui, Akira
    Nagayama, Aiko
    Iwata, Yuko
    Sasahara, Manami
    Murata, Yuya
    ONCOLOGY LETTERS, 2017, 14 (04) : 4135 - 4141
  • [8] Gene expression alterations predict the pathological complete response in triple-negative breast cancer exploratory analysis of the NACATRINE trial
    Freitas, Ana Julia Aguiar
    Nunes, Caroline Rocha
    Mano, Max Senna
    Causin, Rhafaela Lima
    Santana, Iara Viana Vidigal
    de Oliveira, Marco Antonio
    Calfa, Stephanie
    Silveira, Henrique Cesar Santejo
    de Padua Souza, Cristiano
    Marques, Marcia Maria Chiquitelli
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [9] Gene expression alterations predict the pathological complete response in triple-negative breast cancer exploratory analysis of the NACATRINE trial
    Ana Julia Aguiar Freitas
    Caroline Rocha Nunes
    Max Senna Mano
    Rhafaela Lima Causin
    Iara Viana Vidigal Santana
    Marco Antonio de Oliveira
    Stéphanie Calfa
    Henrique César Santejo Silveira
    Cristiano de Pádua Souza
    Márcia Maria Chiquitelli Marques
    Scientific Reports, 13
  • [10] A preliminary study on predicting pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
    Chen, Xi
    Zhou, Zhiguo
    CANCER RESEARCH, 2024, 84 (03)
12345